Skip to content

SPYPHARMA: what changed

BE 0419.976.247NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€147,773
2024 · -€63,710-€84,063
Equity
-€157,859
2024 · -€10,086-€147,773
Cash
€34,146
2024 · €104,963-€70,817
Balance sheet total
€1.6m
2024 · €909,242+€712,114

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€893,844

    up €893,844 (+195%), from €457,230 to €1.4m

    of which Land and buildings: +€648,198

  • Receivables within one year -€105,087

    down €105,087 (-44.6%), from €235,577 to €130,489

    of which Other amounts receivable: -€79,807

  • Cash -€70,817

    down €70,817 (-67.5%), from €104,963 to €34,146

    mainly Investment in fixed assets (net) (-€960,041) and Net result for the year (-€147,773)

Equity and liabilities
  • Debts after one year +€710,582

    up €710,582 (+120%), from €591,472 to €1.3m

  • Profit (loss) carried forward -€147,773

    down €147,773 (-145%), from -€102,002 to -€249,775

  • Other debts +€99,972

    up €99,972 (+182%), from €54,929 to €154,901

  • Current portion of long-term debt +€35,766

    up €35,766 (+125%), from €28,702 to €64,469

  • Short-term financial debts +€30,483

    up €30,483 (+234%), from €13,021 to €43,504

Income statement
  • Other operating charges +€111,484

    up €111,484 (+6,245%), from €1,785 to €113,269

  • Gross operating margin +€95,846

    up €95,846 (+71.9%), from €133,310 to €229,156

  • Depreciation +€41,449

    up €41,449 (+167%), from €24,749 to €66,197

  • Financial charges +€20,205

    up €20,205 (+65.9%), from €30,646 to €50,851

  • Financial income -€4,213

    down €4,213 (-91.0%), from €4,628 to €415

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€63,710
Gross operating margin +€95,846
Staff costs -€2,948
Depreciation -€41,449
Write-downs -€3,630
Other operating charges -€111,484
Other operating items +€4,003
Financial income -€4,213
Financial charges -€20,205
Taxes +€17
Result 2025 -€147,773
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€112,393
Investment -€960,041
Financing +€776,831
Cash 2024 €104,963
Net result for the year -€147,773
Depreciation +€66,197
Stocks and contracts +€7,765
Receivables within one year +€105,087
Deferred charges and accrued income -€1,939
Trade debts -€24,497
Tax, wage and social debts +€7,580
Other debts +€99,972
Investment in fixed assets (net) -€960,041
Debts after one year +€710,582
Current portion of long-term debt +€35,766
Short-term financial debts +€30,483
Cash 2025 €34,146
brings cash intakes cash out
Every line side by side 52 lines
Line Code 2024 2025 Change %
Total assets 20/58 €909,242 €1,621,355 +€712,114 +78.3%
Fixed assets 21/28 €463,804 €1,357,648 +€893,844 +193%
Tangible fixed assets 22/27 €457,230 €1,351,073 +€893,844 +195%
Land and buildings 22 €438,152 €1,086,349 +€648,198 +148%
Plant, machinery and equipment 23 €16,325 €257,690 +€241,365 +1,478%
Furniture and vehicles 24 €2,753 €7,033 +€4,281 +156%
Financial fixed assets 28 €6,575 €6,575 = 0.0%
Current assets 29/58 €445,438 €263,708 -€181,730 -40.8%
Stocks and contracts in progress 3 €100,641 €92,876 -€7,765 -7.7%
Stocks 30/36 €100,641 €92,876 -€7,765 -7.7%
Amounts receivable within one year 40/41 €235,577 €130,489 -€105,087 -44.6%
Trade receivables 40 €98,349 €73,069 -€25,281 -25.7%
Other amounts receivable 41 €137,228 €57,421 -€79,807 -58.2%
Current investments 50/53 €1 €1 = 0.0%
Cash at bank and in hand 54/58 €104,963 €34,146 -€70,817 -67.5%
Deferred charges and accrued income 490/1 €4,256 €6,196 +€1,939 +45.6%
Total equity and liabilities 10/49 €909,242 €1,621,355 +€712,114 +78.3%
Equity 10/15 -€10,086 -€157,859 -€147,773 -1,465%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €73,324 €73,324 = 0.0%
Distributable reserves 133 €73,324 €73,324 = 0.0%
Profit (loss) carried forward 14 -€102,002 -€249,775 -€147,773 -145%
Amounts payable 17/49 €919,328 €1,779,214 +€859,886 +93.5%
Amounts payable after more than one year 17 €591,472 €1,302,054 +€710,582 +120%
Financial debts 170/4 €591,472 €1,302,054 +€710,582 +120%
Amounts payable within one year 42/48 €327,856 €477,160 +€149,304 +45.5%
Current portion of amounts payable after more than one year 42 €28,702 €64,469 +€35,766 +125%
Financial debts 43 €13,021 €43,504 +€30,483 +234%
Credit institutions 430/8 €13,021 €43,504 +€30,483 +234%
Trade debts 44 €223,948 €199,450 -€24,497 -10.9%
Suppliers 440/4 €223,948 €199,450 -€24,497 -10.9%
Taxes, remuneration and social security 45 €7,255 €14,836 +€7,580 +104%
Taxes 450/3 €561 €75 -€486 -86.7%
Remuneration and social security 454/9 €6,694 €14,761 +€8,066 +120%
Other amounts payable 47/48 €54,929 €154,901 +€99,972 +182%
Accrued charges and deferred income 492/3 €0 - =
Non-recurring operating income 76A €814 €0 -€814 -100%
Remuneration, social security and pensions 62 €137,211 €140,160 +€2,948 +2.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €24,749 €66,197 +€41,449 +167%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €3,630 +€3,630
Other operating charges 640/8 €1,785 €113,269 +€111,484 +6,245%
Non-recurring operating charges 66A €7,164 €3,161 -€4,003 -55.9%
Gross operating margin 9900 €133,310 €229,156 +€95,846 +71.9%
Operating profit (loss) 9901 -€37,599 -€97,262 -€59,662 -159%
Financial income 75/76B €4,628 €415 -€4,213 -91.0%
Recurring financial income 75 €4,628 €415 -€4,213 -91.0%
Financial charges 65/66B €30,646 €50,851 +€20,205 +65.9%
Recurring financial charges 65 €30,646 €50,851 +€20,205 +65.9%
Profit (loss) for the period before taxes 9903 -€63,618 -€147,698 -€84,080 -132%
Income taxes 67/77 €92 €75 -€17 -18.9%
Profit (loss) for the period 9904 -€63,710 -€147,773 -€84,063 -132%
Profit (loss) for the period to be appropriated 9905 -€63,710 -€147,773 -€84,063 -132%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.

Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.

Adjusted equity -€157,859

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€157,859
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€157,859

Capitalised earnings

net result for the year (9904)
2025
-€147,773
excluding non-recurring income and charges
-€144,611
2024
-€63,710
excluding non-recurring income and charges
-€57,360
2023
-€38,292
2022
€188,421
2021
€153,199
excluding non-recurring income and charges
€153,501
Average result, excluding non-recurring income and charges
-€80,088
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 15 November 2026 via checked.be.